Halotestin-LA® 10 mg (Fluoxymesterone)
10 mg · 30 tablets · Halotestin-LA® (Fluoxymesterone) is a potent AR-agonist reference steroid used in research on androgen-receptor signaling, protein synthesis, erythropoiesis, and hepatic metabolism of 17-α-alkylated androgens.
€ 39.00
Description
Halotestin-LA® 10 mg (Fluoxymesterone)
Marque : La Pharma
Catégorie : Composé de recherche oral de l'AAS
Contenu : 30 tablets | 10 mg per tablet
Prix : €39
Fabriqué en : Thaïlande
🧪 Aperçu du produit
Fluoxymesterone 10 mg is a high-potency synthetic androgen supplied for laboratory research use.
Its chemical structure includes a 9-fluoro substitution and a 17-α-alkyl group, which grants strong oral bioavailability
while increasing hepatic metabolic load — making it a widely studied compound in toxicology and androgen-receptor signaling research.
With strong affinity for the androgen receptor (AR), fluoxymesterone produces robust transcriptional activation of
androgen-responsive genes, influencing protein synthesis, nitrogen retention, erythropoiesis, and cellular metabolism.
✅ Principaux résultats de la recherche
High-affinity AR agonism:
Fluoxymesterone binds the androgen receptor with strong efficacy, driving protein synthesis and anabolic gene expression.
Oral bioavailability through 17-α-alkylation:
Alkylation reduces hepatic first-pass inactivation, enabling reliable oral dosing in controlled research studies.
Hepatic metabolism & toxicity relevance:
Commonly used in experiments comparing hepatotoxicity profiles of alkylated vs. non-alkylated androgens.
Doping-related research applications:
Listed under AMA S1; useful in method development for detection of exogenous anabolic agents.
🧬 Applications suggérées en laboratoire
- Androgen receptor (AR) binding and transcriptional activation studies
- Protein synthesis and nitrogen-balance research
- Erythropoiesis modeling
- Hepatic toxicity and metabolic pathway studies for 17-α-alkylated AAS
- Comparative AR affinity assays among androgens
📊 Spécifications techniques
| Champ d'application | Valeur |
|---|---|
| Product Name | Halotestin-LA® 10 mg |
| Brand / Manufacturer | La Pharma |
| Form / Strength / Pack | Tablets – 10 mg, 30 tablets |
| Country of Origin | Thaïlande |
| Research-Only Notice | Laboratory research use only; not for human consumption |
| Nom chimique | Fluoxymesterone |
| IUPAC (Short) | 9-fluoro-11β,17β-dihydroxy-17α-methylandrost-4-en-3-one |
| Synonymes | Halotestin; 9-fluoro-11,17-dihydroxy-17-methyltestosterone |
| Numéro CAS | 76-43-7 |
| Molecular Formula | C20H29FO3 |
| Poids moléculaire | ≈ 336.45 g/mol |
| Primary Target | Androgen receptor (AR) agonist |
| Oral Bioavailability Rationale | 17-α-alkylation reduces hepatic first-pass deactivation |
| Key Literature Risks | Cholestatic hepatitis, liver enzyme elevation, androgenic effects, lipid changes |
| Anti-Doping Status | WADA S1 Anabolic Agents (prohibited) |
❄️ Perspectives de recherche soutenues par PubChem
- High-affinity AR activation producing strong anabolic transcription
- Oral steroid metabolism pathways involving fluorinated and alkylated groups
- Hepatotoxicity signals common to 17-α-alkylated androgens
- Useful in forensic/anti-doping detection modeling
- Supports mechanistic studies contrasting AR potency among synthetic androgens
⚠️ Effets secondaires documentés par la recherche
- Cholestatic liver injury and transaminase elevation
- Androgenic dermatological effects (acne, oiliness)
- Lipid imbalance (↓ HDL / ↑ LDL)
- Fluid retention and blood-pressure modulation
- Endocrine suppression affecting reproductive pathways
🧯 Manipulation et conformité
Réservé à la recherche — not for human or veterinary use.
Store sealed, protected from light, at stable room temperature.
Fluoxymesterone is controlled and prohibited in sports; ensure legal and institutional compliance.
Proper documentation, safe handling, and restricted access are required.
Il n'y a pas encore de commentaires.
